Dysrhythmias VI: Management of Dysrhythmias
Hypertension IV: Drug Therapy and Lifestyle Modifications
Angina IV: Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 1, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
1Lankenau Medical Center, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
Physicians often misjudge stroke risk in atrial fibrillation (AFib) patients. This review emphasizes stroke prevention through anticoagulation, highlighting the limitations of warfarin and the benefits of newer agents, alongside improved risk assessment tools.
Area of Science:
Background: